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Abstract
Background: Foot problems are highly prevalent in people with inflammatory arthritis reported from studies in the
UK, Europe and New Zealand, but there is limited evidence from Southeast Asia. The study aim was to evaluate the
prevalence of foot problems in people with inflammatory arthritis in Singapore.
Methods: People with inflammatory arthritis were recruited from the rheumatology outpatient clinic of a tertiary
hospital in Singapore. Disease and clinical characteristics included age, sex, disease duration, current blood tests and
medications. The Leeds Foot Impact Scale was used to evaluate foot impairment/disability and the Modified Health
Assessment Questionnaire was used to assess global function.
Results: We recruited 101 people with inflammatory arthritis, of which 50 % were female. The majority of
participants were Chinese (70 %). The mean (SD) age was 52 (15) years, and the mean (SD) disease duration was 9.3
(0.3) years. The most commonly reported inflammatory arthritic conditions were rheumatoid arthritis (46), gout (31)
and spondyloarthritis (15 %). The mean (SD) of the total Leeds Foot Impact Scale was 17 (13) indicating moderate
to severe levels of foot impairment and activity limitation. Over 80 of participants reported foot pain during the
course of their condition, and 48 % reported current foot pain. Despite the high prevalence of foot pain, only 21
participants (21 %) had been referred to a podiatrist.
Conclusion: This is the first study to investigate the prevalence of foot problems in people with inflammatory
arthritis from Singapore. The majority of the participants reported foot problems, but had not been referred to a
podiatry service.
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Background
Foot problems associated with inflammatory arthritis
(IA) are common, particularly in Rheumatoid arthritis
(RA) [1, 2]. Other IA conditions such as gout, spondy-
loarthritis (Spa) and psoriatic arthritis (PA) also affect
the foot [3–5]. However, our knowledge of the epidemi-
ology of foot involvement is based on studies among
Caucasians derived primarily from Western countries [2,
6–8] with data currently dominated by studies focusing
predominantly on people with RA [9]. While the magni-
tude of foot impairments and related disability in IA is
comparable to that reported in RA [5, 10], relatively few
studies to date have focused on IA foot and ankle char-
acteristics from a Southeast Asian population.
RA affects approximately 0.4 % to 0.8 % of the adult
population worldwide [11]. It is less prevalent in main-
land China and in Hong Kong, with a reported preva-
lence of 0.37 and 0.35 %, respectively [12–14]. In
Singapore, RA is the most common form of IA, affecting
about 1 % of the population, equivalent to an estimated
45,000 people [15].
Previous studies of Chinese people have been largely
population-based prevalence surveys [13, 16]. These
studies suggest that RA in Asians behaves differently
from that in Caucasians, such as a relatively greater in-
volvement of the wrist joint and a milder disease course
[13, 17, 18]. However, IA-related foot problems can be
inadequately understood or overlooked during rheuma-
tology consultations [19]. The aim of this study was to
identify the prevalence of foot problems in people with
IA attending a rheumatology outpatient clinic in
Singapore.
Method
Participants
Participants were recruited from a rheumatology out-
patient clinic in Singapore between January 2015 and
November 2015. Each inflammatory arthritic condition
was based upon medical records and referred by the
rheumatologists to the podiatric service. Participants
were eligible if they were over 21 years old,
rheumatologist-diagnosed inflammatory joint disease
and with or without current foot pain. Those with cogni-
tive impairment precluding ability to answer health-
related questions accurately were excluded. A conveni-
ence sample of 100 participants was predetermined
based on a previous study [7]. Each participant attending
the clinic was asked to consent to a foot health assess-
ment and to complete a questionnaire. All assessments
were conducted by an experienced podiatrist. Ethics ap-
proval was obtained from the National Healthcare
Group Domain Specific Review Board Singapore. All
participants provided written informed consent prior to
data collection.
Podiatry services in Singapore are provided at the 6
public hospitals and by a small private sector. Singapore
has approximately 80 podiatrists currently working, with
most of them employed by the public hospitals. A team
of 8 podiatrists works in the hospital in this study. Pa-
tients mainly access podiatry services by referral from a
doctor. Most referrals come from within the hospital,
with a small number coming from private family doctors
and patient self-referral. A referral by internal doctor af-
fords a government subsidy for the patient, which re-
duces their treatment charges by 50 %. Direct referral by
a private family doctor and self-referral incurs full non-
subsidized charges. At the rheumatology outpatient
clinic where the study was conducted there are 13 rheu-
matologists and 25–30 clinics per week of mixed IA
caseloads. During the period of the study there was no
formally integrated multidisciplinary service operating;
referral to podiatry was dependent on referrals from in-
dividual doctors, their decision to do so based on their
knowledge of allied health care services or the willing-
ness of the patient to be referred.
Clinical characteristics
Clinical characteristics included the type of IA, disease
duration, current medications, erythrocyte sedimenta-
tion rate (ESR) and C-reactive protein (CRP). For those
participants with a previous foot x-ray the presence of
radiographic foot erosions was recorded by reviewing
the radiology reports for presence of erosions as docu-
mented within the clinical records. Global pain was
measured using a 100 mm Visual analogue scale (VAS).
The Disease Activity Score in 28-joints using the ESR
(DAS28-ESR) was calculated for those people with RA
and a same-day ESR result [20]. Responses to the Modi-
fied Health Assessment Questionnaire (MHAQ) - a
physical function status questionnaire used in the evalu-
ation of a variety of rheumatic diseases - were also re-
corded [21]. The MHAQ asks participants to answer 8
questions, 1 in each of the 8 functional areas [21]. The
MHAQ assesses the degree of difficulty experienced
with undertaking specific tasks over the preceding week.
MHAQ scores are converted to a range between 0 and
3; with 0 to 1 indicating mild/moderate functional im-
pairment, 1.1 to 2 is moderate/severe, and 2.1 to 3 indi-
cating severe/very severe impairment [22].
Foot and ankle characteristics
Foot and ankle characteristics included the Leeds Foot
Impact Scale (LFIS) - a disease specific scale for measur-
ing the impact of foot disease. The LFIS is a self-
completed questionnaire comprising 51 items in total,
divided into two subscales: impairments/shoes (LFISIF)
and activities/participation (LFISAP) [23]. Turner and
Woodburn [24] reported a LFISIF score of >7 and
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LFISAP score of >10 as representing a high to severe
level of foot impairment and disability.
The Foot posture index (FPI) was used to assess foot
type [25]. The Structural index (SI) evaluated forefoot
and rearfoot deformities [26]. SI forefoot scores of ≥10
and rearfoot scores of ≥4 indicate the presence of severe
foot deformity [24]. The Manchester scale evaluated the
severity of hallux valgus [27]. Participants Previous and
current foot pain was recorded Experience of current
and previous foot pain and previously seen a podiatrist
were recorded as dichotomous responses. Foot lesions
that foot ulceration were noted. All demographic and
disease activity data were presented as means and stand-
ard deviations (SD), and foot assessments as numbers
and percentages.
Results
The demographic and clinical characteristics of all par-
ticipants are shown in Table 1. Additional file 1 demon-
strates the demographic and clinical characteristics of
each inflammatory arthritic condition that included RA
(n = 46, 46), gout (n = 31, 31), Spa (n = 15, 15), PA (n = 4,
4) and undifferentiated IA (n = 5, 5 %). We recruited 101
participants, the majority of participants being Chinese
women with a mean (SD) age of 52 (15) years. The ma-
jority of participants with RA were women (n = 37, 80)
and men with gout (n =25, 81 %). The most commonly
reported IA conditions were RA (n = 46, 46), gout (n =
31, 31) and spondyloarthritis (n = 15, 15 %). The mean
(SD) disease duration across all IA conditions was 9.3
(0.3) years. The mean (SD) for BMI of 30.7 (5.0) Kg/m2
in gout was high compared to the other IA conditions.
The MHAQ found mild overall functional impairment
with a mean (SD) score of 0.25 (0.36). Blood markers
(CRP and ESR) indicated high levels of inflammation in
the 41 participants with RA.
The foot and ankle characteristics are summarized in
Table 2 with Additional file 1 demonstrating each spe-
cific IA condition. Over 80 % of participants (n = 81) re-
ported having experienced foot pain during the course
of their disease, with over 95 % of participants with gout
reporting previous foot pain. Nearly 50 % of participants
(n = 48) reported current foot pain, of which 45 (45 %)
reported daily foot pain. Participants with RA reported
current foot pain (n =28, 61 %), whereas only 7 (23 %)
participants with gout reported current foot pain. Only
21 % participants had been referred to a podiatrist.
The total mean (SD) of the LFIS was 17 (13). The
mean (SD) for the LFISIF was 7 (7) and the LFISAP 10
(9) indicating moderate to severe levels of foot impair-
ment and activity limitation. Participants with RA re-
corded higher levels of foot impairment and disability.
The mean (SD) SI forefoot score of 4.9 (4.2) and the SI
rearfoot score of 3.5 (3.3) demonstrated moderate levels
of foot deformity. All participants with PA (n = 4, 100 %)
were found to have high levels of rearfoot deformity.
The FPI demonstrated a mean (SD) score of 4 (6).
Discussion
The study demonstrates that foot problems are highly
prevalent in people with IA attending the rheumatology
outpatient clinic in Singapore. This study is the first to re-
port prevalence of IA-related foot problems in a Southeast
Asian population. Compared to the proportions of the
main ethnic groups in Singapore this study demonstrates
a representative sample [28]. The demographic and
Table 1 Demographic and clinical characteristics
Age, years 52.0 (14.5)
Women, n (%) 51 (50 %)
Ethnicity, n (%)
Chinese 70 (69 %)
Malay 11 (11 %)
Indian 15 (15 %)
Caucasian 0 (0 %)
Other 5 (5 %)
Body Mass Index, Kg/m2 27.2 (5.4)
Smokers, n (%) 14 (14 %)
Disease duration, years 9.3 (0.3)
Disease type, n (%)
• Rheumatoid arthritis 46 (46 %)
• Gout 31 (31 %)
• Spondyloarthritis 15 (15 %)
• Psoriatic arthritis 4 (4 %)
• Undifferentiated inflammatory arthritis 5 (5 %)
Medications, n (%)
• Methotrexate 42 (60 %)
• Combination DMARD therapy (≥2 DMARDs) 52 (74 %)
• Biologics 4 (6 %)
• Prednisone 40 (40 %)
Other medications, n (%)
NSAID, n (%) 49 (49 %)
Diabetes Mellitus, n (%) 12 (12 %)
Patient global VAS (VAS 0–100), mm 26 (26)
Tender (28) joint count 1.8 (2.8)
Swollen (28) joint count 1.3 (2.1)
DAS28-ESR score 3.54 (1.1)
ESR, mm/h 31.6 (21.2)
CRP, mg/L 27.4 (32.2)
mHAQ score 0.25 (0.36)
Data presented as mean (SD) unless specified
DMARD Disease modifying anti-rheumatic drug, NSAID Non steroidal anti-
inflamamtory drugs, VAS Visual analogue scale, ESR Erythrocyte sedimentation
rate, CRP C-reactive protein, DAS-28 disease activity score in 28 joints
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clinical characteristics of this IA cohort were consistent
with other epidemiological studies from the UK and New
Zealand [1, 3, 29–31]. In the current study 81 % of partici-
pants reported having had foot pain. Previous studies
evaluating foot involvement in RA report involvement in
56–100 % of people [2, 6, 7, 32–34].
Current foot pain was reported by 48 % of patients
with IA, noting a high prevalence in people with RA.
Pain is the commonest problem facing patients with IA
both generally and specifically related to their feet [31].
We found the data to be lower than has been previously
reported in people with RA [6] and gout [35]. The differ-
ences may be due to previous studies being conducted
in Western countries compared to Asian countries with
regard to social, cultural and ethnic compositions [36].
However, there is limited information specifically to the
foot in people with gout and RA in Asian populations.
We found the DAS28 demonstrated moderate levels of
disease activity and the raised ESR and CRP suggests in-
creased levels of inflammation. However, the DAS28
does not provide a measure of foot involvement, thus
patients may be at risk of ongoing joint damage if treat-
ment decisions are made solely on the basis of the DAS
[37]. Given that patients can report severe symptoms in
their feet, and these general health tools omit the feet, it
is vital that foot health assessment tools are used in
combination with the general disease assessment tools.
There is evidence that early intervention for existing or
potential foot problems can improve long-term outcomes
[38, 39]. Previous studies suggest that for people with IA,
the involvement of the feet, even to a mild degree, is a sig-
nificant marker for future impaired mobility, functional
incapacity and negative psychosocial impact [7, 40]. Fol-
lowing diagnosis of IA a referral to a podiatrist for baseline
assessment, tailored foot health education, self-care advice
and necessary intervention, is recommended [40, 41].
However, with over one third of participants with moder-
ate to severe foot impairment and moderate levels of foot-
specific pain and deformity, very few patients had actually
been referred for podiatry assessment. Greater emphasis
on raising awareness of foot problems and podiatry care
for people with IA is required in Singapore. Guidelines
strongly advocate referral to a podiatrist for essential foot
health management [40, 41]. Integration of podiatry ser-
vices within the rheumatology multidisciplinary team
(MDT) could resolve unmet need of people with current
or potential IA-related foot problems. Emerging evidence
suggests that tight pharmacological control, in conjunc-
tion with MDTcare, including podiatry, can be effective in
the management of people with IA [38, 42]. Further work
is required to improve access to podiatry for people with
IA in Singapore. Future developments should include the
integration of specialist podiatrists into the MDT with
emphasis on improving the quality and timeliness of
patient care.
We found that only 21 % of participants had been re-
ferred to podiatry services. The strongest barriers pre-
venting uptake of podiatry services appear to be:
financial constraints (even with a subsidy out-of-pocket
payment at the point of care can vary considerably for
each service and for each patient, and therefore the cost
to the patient plays a major role in healthcare decisions),
lack of patient and /or doctor awareness and under-
standing of the role of podiatry, and low priority given
to allied-health interventions by patients. Similar barriers
have previously been reported in Australia [3, 43].
Limitations of this study may potentially be a lack of
external validity as people were recruited from one ter-
tiary hospital in Singapore and therefore, a true preva-
lence of foot problems is unknown. The sample of
people attending the outpatient clinic may have resulted
in selection bias. The study may also suffer from recall
bias as some of the questions referred to events that oc-
curred when the people were first diagnosed, past ap-
pointments and interventions and self-reporting of
Table 2 Foot and ankle characteristics
Foot erosion on radiograph, n (%) 19 (40 %)a
Previous foot surgery, n (%) 9 (9 %)
Presence of current foot pain, n (%) 48 (48 %)
Previous foot pain, n (%) 81 (81 %)
Current foot ulceration, n (%) 1 (1 %)
Structural Index
Forefoot score 4.9 (4.2)
Rearfoot score 3.5 (3.3)
Total Structural Index 8.4 (6.2)
Foot Posture Index foot-type 4 (6)
Callus Patterns:
Forefoot, n (%) 12 (12 %)
Rearfoot, n (%) 0 (0 %)
Toes, n (%) 6 (6 %)
Severity of bunion, n (%)
Stage 1 48 (48 %)
Stage 2 25 (25 %)
Stage 3 18 (18 %)
Stage 4 10 (10 %)
Has seen a podiatrist before, n (%) 21 (21 %)
FISTOTAL score 17 (13)
FISIF subscale score 7 (5)
FISAP subscale score 10 (9)
Data presented as mean (SD) unless specified
FISTOTAL Foot Impact Score total, FISIF Foot Impact Score foot impairment/
footwear restriction, FISAP Foot Impact Score activity
limitation/participation restriction
a48 participants underwent foot X-rays
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disease duration. We recruited from a mixed rheumatol-
ogy caseload and grouped different IA conditions to-
gether for analysis, whereas previous studies have
focused on a single condition such as RA [6, 7] or gout
[35]. Although our findings are a true representation of
the current service in Singapore, using a heterogeneous
cohort potentially limits study comparison, analysis of
specific differences and generalizability of findings.
The Leeds Foot Impact Scale was developed specifically
to assess the rheumatoid foot, and has demonstrable
measurement properties, such as reliability, construct val-
idity, responsiveness, and wide applicability for the evalu-
ation of the impact of disease on the feet [44]. However,
anecdotal evidence from the current study identified that
participants found it difficult to complete. Although there
were no non-responses to the use of Leeds Foot Impact
Scale, we observed that a minority of people were unable
to comprehend the wording of the questions, especially if
English was not their first language. Multiple generic and
disease-specific foot scales are available in the English lan-
guage [44]. Others such as the Foot Function Index, a gen-
eric foot scale, has undergone successful cross-cultural
validation in several languages including Dutch, German
and Taiwan Chinese [45–47]. The Leeds Foot Impact
Scale is disease-specific, has been translated to Dutch,
German and Hungarian [48]. Singapore’s majority popula-
tion is Chinese and many older Singaporeans are not suffi-
ciently proficient in the English language to enable
questionnaire data to be collected without the aid of a
translator. Additional work is required to validate a trans-
lated foot-specific patient reported outcome measure in
simplified Chinese to facilitate further research into IA-
related foot pain in Asian communities. Validated out-
come tools that are cross-culturally invariant will also pro-
vide opportunity for wider international collaboration and
comparison between populations.
Conclusion
In conclusion, this is the first study to identify foot prob-
lems and uptake of podiatry services in people with IA
in Singapore. The uptake of the podiatry service was
poor and there is a need for foot-specific patient
reported outcome measure in simplified Chinese to
facilitate further research into IA-related foot pain, im-
pairment and disability in Asian communities. The study
highlights an unmet need for podiatry involvement and
lack of compliance with international guidelines.
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